As a result of a number of recently reported equine fatalities associated with the use of Medroxyprogesterone (MPA), US Equestrian will reconvene its MPA Panel to further analyze the use of this substance in horses competing at USEF-licensed competitions.
This latest information on equine fatalities associated with the use of MPA underscores the need for the MPA Panel to meet and review the critical information about this substance in order to provide our members with the information they need to protect their equine partners.
The MPA Panel was first convened in the winter to 2017 due to discussion in the veterinary community and the emergence of research regarding the efficacy of MPA in competition horses. Specifically, the question focused on how MPA affects the competition horse, since research indicated that MPA does not interrupt estrus in mares. This was especially important due to its increased use in geldings and stallions, and also to the reports of increased dosages being administered.
Following discussions at public hearings and town halls, as well as feedback from our members, the MPA Panel recommended that we continue to monitor the use of MPA, including implementation of MPA-specific medication reports in order to capture more information on dosage, administration schedules, and the continued presence of the substance in a horse’s system after the last known administration. However, the recent reports of equine fatalities have raised greater concern regarding the safety of this substance in horses.
US Equestrian remains steadfast in our efforts to protect human and equine athletes. As such, we will update our membership on any changes to the permitted use of MPA. In the interim, USEF strongly discourages the use of MPA by its members and also recommends that you consult with your veterinarian.
Specifics of the "Fun & Education Formula" were provided to all at the Jim Wofford Clinic held on August 20 & 21 at the Horse Park in Woodside, northern California. Eager riders, auditors, and volunteers gathered for a much anticipated two-day clinic with the master bright and early Saturday morning.
This year a new class will be joining the 47 eventing legends currently in the United States Eventing Association (USEA) Eventing Hall of Fame. Induction into the Hall of Fame is the highest honor awarded within the sport of eventing in the United States. Those invited to join the USEA's Eventing Hall of Fame have truly made a difference in the sport of eventing. Hall of Fame members have included past Association presidents, volunteers, riders, founders, course designers, officials, organizers, horses, horse owners, and coaches.
Have you ever wondered why your horse isn’t performing at their best? Get ready to learn about the many facets that can contribute to lameness and poor performance in sport horses from equine orthopedics expert, Dr. Sue Dyson! The United States Eventing Association (USEA) is pleased to announce that Dr. Dyson will be the keynote speaker at the 2022 USEA Annual Meeting & Convention in Savannah, GA this December 7-11.
Rosie Smith’s rose gold accented helmet matched her perfectly tidy bun of red hair as she took the third spot in the USEA Training Rider Championship at the 2022 USEA American Eventing Championships (AEC) presented by Nurena Feeds. Every little detail came together while aboard her trusted partner of nine years: the 20-year-old Connemara Irish Draught named Seamus (by Corrcullen, RID). But Smith’s first jump, back when she was only 15 years old, wasn’t with an English saddle.